US20130023873A1 - Control methods and devices for energy delivery - Google Patents

Abstract

Control systems and methods for delivery of energy that may include control algorithms that prevent energy delivery if a fault is detected and may provide energy delivery to produce a substantially constant temperature at a delivery site. In some embodiments, the control systems and methods may be used to control the delivery of energy, such as radiofrequency energy, to body tissue, such as lung tissue.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS
• This application claims the benefit under 35 U.S.C. §119(e) of U.S. Provisional Application No. 60/674,106 filed Apr. 21, 2005, the contents of which are incorporated herein by reference.
BACKGROUND
• Various obstructive airway diseases have some reversible component. Examples include COPD and asthma. Asthma is a disease in which bronchoconstriction excessive mucus production and inflammation and swelling of airways occur, causing widespread but variable airflow obstruction thereby making it difficult for the asthma sufferer to breathe. Asthma is a chronic disorder, primarily characterized by persistent airway inflammation. Asthma is further characterized by acute episodes of additional airway narrowing via contraction of hyper-responsive airway smooth muscle.
• In susceptible individuals, asthma symptoms include recurrent episodes of shortness of breath (dyspnea), wheezing, chest tightness and cough. Currently, asthma is managed by a combination of stimulus avoidance and pharmacology. Stimulus avoidance is accomplished via systemic identification and minimization of contact with each type of stimuli. It may, however, be impractical and not always helpful to avoid all potential stimuli.
• Pharmacological management of asthma includes long term control through the use of anti-inflammatories and long-acting bronchiodilators. Short term pharmacological management of acute exacerbations may be achieved with use of short-acting bronchiodilators. Both of these approaches require repeated and regular use of prescribed drugs. High doses of corticosteroid anti-inflammatory drugs can have serious side effects that require careful management. In addition, some patients are resistant to steroid treatment. The difficulty involved in patient compliance with pharmacologic management and the difficulty of avoiding stimulus that trigger asthma are common barriers to successful conventional asthma management. Accordingly, it would be desirable to provide a management system and method that does not require regular patient compliance.
• Various energy delivering systems have been developed to intraluminally treat anatomical structures by the controlled application of energy to intraluminal surfaces. Such systems may be specifically configured to deliver energy to lung tissue because of the clinical demands caused by the heterogeneous nature of lung tissue, and specifically, variations in lung tissue lumen size due to the branching pattern of the tracheobronchial tree, variations in the vasculature of the lungs and variations in the type of tissue in the lungs, including cartilage, airway smooth muscle, and mucus glands and ducts. Accordingly, a system designed to delivery energy, and in some particular cases, radiofrequency energy, to lung tissue must take these variations into account and deliver energy in a controlled manner.
• Medical procedures involving the controlled delivery of therapeutic energy to patient tissue are often demanding and may require a physician to perform several tasks at the same time. In addition, medical procedures or other procedures may require specific energy delivery parameters. As such, what has been needed is an energy delivery system with a user friendly control system that regulates and controls the delivery of energy, prevents operation or energy delivery if a fault in the energy delivery system is detected by the control system and provides the user with information delivered in an easy to understand format so that the information can be readily analyzed during a demanding medical procedure.
SUMMARY
• In one embodiment, a system for delivering activation energy to a therapeutic energy delivery device having a temperature detecting element and an energy emission element includes an energy generator configured to be coupled to the energy emission element. The energy generator has an activation state and a standby state, where activation energy is delivered to the energy emission device in the activation state and not in the standby state. A controller having a processor and a user interface surface with a visual indicator is coupled to the energy generator and the processor is configured to activate the visual indicator when a temperature measured by the temperature detecting element is not within a pre-determined temperature range.
• In another embodiment, an energy delivery system includes a therapeutic energy delivery device having a distal portion configured to be delivered to a treatment site. The distal portion includes a temperature detecting element and an energy emission element. An energy generator is configured to be coupled to the energy emission element and has an activation state and a standby state, where activation energy is delivered to the energy emission element in the activation state and not in the standby state. A controller having a processor and a user interface surface with a visual indicator is configured to activate the visual indicator when a temperature measured by the temperature detecting element is not within a pre-determined temperature range.
• In another embodiment, a system for delivering activation energy to a therapeutic energy delivery device having a temperature detecting element and an energy emission element includes an energy generator configured to be coupled to the energy emission element. The energy generator has an activation state and a standby state, where activation energy is delivered to the energy emission device in the activation state and not in the standby state. A controller having a processor and a user interface surface with a visual indicator is configured to activate the visual indicator when an impedance of an energy emission circuit between the energy generator, the energy emission element and a patient is not within a pre-determined impedance range.
• In another embodiment, an energy delivery system includes a therapeutic energy delivery device having a temperature detecting element and an energy emission element. An energy generator is configured to be coupled to the energy emission element and has an activation state and a standby state, where activation energy is delivered to the energy emission element in the activation state and not in the standby state. A controller having a processor and a user interface surface with a visual indicator is configured to activate the visual indicator when an impedance of an energy emission circuit between the energy generator, the energy emission element and a patient is not within a pre-determined impedance range.
• In yet another embodiment, a system for delivering activation energy to a therapeutic energy delivery device having a temperature detecting element and an energy emission element includes an energy generator configured to be coupled to the energy emission element. The energy generator has an activation state and a standby state, where activation energy is delivered to the energy emission device in the activation state and not in the standby state. A controller having a processor and a user interface surface with a first visual indicator and a second visual indicator, is configured to activate the first visual indicator when a temperature measured by the temperature detecting element is not within a pre-determined temperature range and to activate the second visual indicator when an impedance of an energy emission circuit between the energy generator, the energy emission element and a patient is not within a pre-determined impedance range.
• In another embodiment, an energy delivery system includes a therapeutic energy delivery device configured to be delivered to a treatment site. The energy delivery device has a temperature detecting element and an energy emission element. An energy generator is configured to be coupled to the energy emission element and has an activation state and a standby state, where activation energy is delivered to the energy emission element in the activation state and not in the standby state. A controller having a processor and a user interface surface with a first visual indicator and a second visual indicator is configured to activate the first visual indicator when a temperature measured by the temperature detecting element is not within a pre-determined temperature range and to activate the second visual indicator when an impedance of an energy emission circuit between the energy generator, the energy emission element and a patient is not within a pre-determined impedance range.
• In another embodiment, an energy delivery system includes a therapeutic energy delivery catheter having an electrode and temperature detecting element disposed on a distal portion of the catheter. The distal portion of the catheter is configured to be delivered to a treatment site adjacent target tissue of a patient and deliver a treatment cycle of therapeutic RF energy to the target tissue. An RF energy generator is configured to be coupled to the electrode and has an activation state and a standby state, where RF energy is delivered to and emitted from the electrode in the activation state and not in the standby state. A controller having a processor and a user interface surface with a first visual indicator and second visual indicator is configured to process temperature measurements taken by the temperature detecting element and impedance measurements between the RF energy generator and the target tissue prior to activation of the RF energy generator to the activation state. The processor is also configured to activate the first visual indicator if a temperature measured by the temperature detecting element is not within a pre-determined temperature range and activate the second visual indicator when an impedance between the RF energy generator and target tissue adjacent the electrode is above a predetermined value.
• These features of embodiments will become more apparent from the following detailed description when taken in conjunction with the accompanying exemplary drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
• FIG. 1 is a schematic view of a system for delivering energy to the wall tissue of a patient's lung.
• FIG. 2 is an enlarged view of a distal portion of a therapeutic energy delivery device.
• FIG. 3 is an enlarged view of theencircled portion3 inFIG. 2 illustrating a more detailed view of an energy emission element and temperature detecting element of the therapeutic energy delivery device.
• FIG. 4 is an elevational view of a user interface surface of a controller.
• FIGS. 5A and 5B are flow diagrams depicting various processes and routines that control the user interface surface elements.
DETAILED DESCRIPTION
• Embodiments of systems and methods for delivering energy to tissue of a patient in a controlled manner are discussed, and specifically, systems and methods for controlled delivery of radiofrequency (RF) energy to lung tissue, bronchial tissue or both. Embodiments of the systems and methods may be configured to consolidate and effectively communicate relevant information to a user of the systems, including detecting accessory connections (e.g. therapeutic device, footswitch, electrode return pad, or other) and serving as an automatic trouble shooting guide with user friendly instructions, information, indicators and the like.
• FIG. 1 shows a schematic diagram of a system for deliveringtherapeutic energy10 to tissue of a patient having anRF energy generator12, acontroller14 coupled to the energy generator, auser interface surface16 in communication with thecontroller14 and a therapeutic energy delivery device, in the form of an RFenergy delivery catheter18, coupled to aninterface coupler20 on theuser interface surface16. Thecontroller14, which is coupled to theenergy generator12 anduser interface surface16, is configured to control the energy output of theenergy generator12. Theuser interface surface16 may include switches, a digital display, visual indicators, graphical representations of components of the system and an audio tone generator as well as other features. Thecontroller14 includes aprocessor22 that is generally configured to accept information from the system and system components, and process the information according to various algorithms to produce control signals for controlling theenergy generator12. Theprocessor22 may also accept information from thesystem10 and system components, process the information according to various algorithms and produce information signals that may be directed to the visual indicators, digital display or audio tone generator of the user interface in order to inform the user of the system status, component status, procedure status or any other useful information that is being monitored by the system. Theprocessor22 of thecontroller14 may be digital IC processor, analog processor or any other suitable logic or control system that carries out the control algorithms. Some of the control alerts, information, feedback and testing routines are shown in the flow diagrams ofFIGS. 5A and 5B.
• Thesystem10 also includes anelectrode return pad24 and afootswitch26, both of which are coupled torespective interface couplers28 and30 on theuser interface surface16. Theuser interface surface16 also includes adigital display32 that may be used to display numeric data to a user of thesystem10. The arrangement of theuser interface surface16 provides a user friendly interface for thesystem10 that provides feedback and system information to a user in an intuitive display format. System components that couple to theuser interface surface16, such as thefootswitch26, electrode returnconductive pad24 andenergy delivery catheter18, couple to theuser interface surface16 adjacent graphical representations of the respective system components. In addition, visual indicators that are configured to display information about these various system components may also be disposed adjacent or within the respective graphical representation of each system component. This configuration allows a user to easily and intuitively couple system components to the proper interface on theuser interface surface16 and also allows a user to easily and intuitively correlate audio and visual system feedback to the appropriate system component.
• Referring again toFIG. 1, theenergy delivery catheter18 includes anelongate shaft34, ahandle36 secured to a proximal end of theelongate shaft34 and acontrol cable38 that extends from thehandle36 to aproximal coupler40 that is configured to couple to theinterface coupler20 on theuser interface surface16. A slidingactuator42 on thehandle36 controls the radial expansion and contraction of adistal electrode basket44 disposed on a distal end of theelongate shaft34. Theelongate shaft34 may have a variety of configurations, including stiff, flexible, steerable with distal tip deflection and the like. Theelongate shaft34 and distal portion may also be configured and sized to permit passage of theelongate shaft34 through the working lumen of a commercially available bronchoscope. In addition, thecontroller14 may also include an optional interface coupler (not shown) that is configured to couple to a bronchoscope camera trigger such that when theprocessor22 of thecontroller14 initiates a treatment cycle by switching the RF energy generator from a standby state to an activation state, a triggering signal is also generated by the controller to initiate video taping or displaying of an image produced by the bronchoscope camera which is coupled to a bronchoscope being used to position theenergy delivery catheter18 during a procedure or treatment cycle. Alternatively, an interface couple may provide the ability to send some or all of the controller output or feedback to the bronchoscope video processor or monitor. This feature allows display of information ordinarily on the controller's user interface surface to display on any of the bronchoscope video monitors. Additionally, additional controller output information that is not displayed on the controller's user interface surface can be displayed on any of the displays associated with the bronchoscope. This feature allow the physician to focus on the bronchoscope display monitor when performing a procedure.
• Thedistal electrode basket44 may be seen in more detail inFIGS. 2 and 3. Thedistal electrode basket44 is a flexible and resilient oval shaped basket that includes an energy emission element in the form of anelectrode46 that is formed from an exposed section of a basket leg48 which is nominally coated with anelectrical insulator material50 in the areas outside of the exposed section. Thedistal electrode basket44 also includes a temperature detection element in the form of athermocouple52 disposed on or adjacent theelectrode46. Thethermocouple52 has leads54 and thermocouple termination points56 which are secured to the exposedsection58 of the basket leg orelectrode46.
• The leads54 of thethermocouple52 and a conductor (not shown) in electrical communication with theelectrode46 extend proximally from thedistal basket44 to thehandle36 and then proximally through thecontrol cable38 to theproximal coupler40. This configuration allows theelectrode46 and the thermocouple leads54 to be electrically coupled in a modular arrangement with thecontroller14 through theuser interface surface16. Theinterface coupler20 configured to accept theproximal coupler40 of theenergy delivery catheter18 is disposed adjacent agraphical representation60 of an embodiment of theenergy delivery catheter18 which, is printed on theuser interface surface16. This provides a useful visual prompt for a user who is setting up thesystem10. Once theproximal coupler40 is connected to theinterface coupler20 for theenergy delivery catheter18, theelectrode46 is now in electrical communication with theRF energy generator12, subject to control and modulation by thecontroller14 which may switch theRF generator12 back and forth between an active state and a standby state, during which no RF can be delivered. In addition, theleads54 of thethermocouple52 are also in electrical communication with thecontroller14 so that thecontroller14 may monitor the temperature of the tissue adjacent theelectrode46. In this arrangement, theRF energy generator12,controller14 anduser interface16 form a system for controlled delivery of activation energy to theenergy delivery catheter18.
• Theelectrode46 may be monopolar or bipolar, however, if theelectrode46 is a monopolar electrode, areturn electrode component62 may be used with thesystem10 in order to complete an electrical energy emission or patient circuit between theRF energy generator12 and a patient (not shown). Theelectrode return62 includes theconductive pad24, aproximal coupler64 and aconductive cable66 extending between and in electrical communication with theconductive pad24 andproximal coupler64. Theconductive pad24 may have a conductive adhesive surface configured to removably stick to the skin of a patient and with a large enough surface area such that no burning or other injury to the patient's skin will occur in the vicinity of theconductive pad24 while thesystem10 is in use. Theproximal coupler64 is configured to couple to theinterface coupler28 on theuser interface surface16. Theinterface coupler28 for theelectrode return62 is disposed adjacent agraphical representation68 of theelectrode return62 on theuser interface surface16. Once again, this provides a useful visual prompt for a user who is setting up thesystem10.
• Once theproximal coupler40 of theenergy delivery catheter18 and theproximal coupler64 of theelectrode return62 have been coupled to thecontroller14 via therespective interface couplers20 and28 of theuser interface surface16, RF energy may be generated by theRF generator12, i.e., theRF generator12 is switched to an activation state, and emitted from theelectrode46 of thedistal basket44 of theenergy delivery catheter18 into target tissue of the patient adjacent theelectrode46. Theprocessor22 may then adjust the output of theRE generator12 in order to maintain a substantially constant temperature of tissue adjacent the electrode via a feedback loop between thethermocouple52 and theprocessor22. Theprocessor22 may use a control algorithm to process the temperature feedback and generate control signals for theRE generator12. In addition, the control algorithm may be configured to set predetermined dwell or activation times for embodiments of treatment cycles. Embodiments of control algorithms and system components that may be used in conjunction with control device and method embodiments discussed herein may be found in U.S. patent application Ser. No. 10/414,411, titled “Control System and Process for Application of Energy to Airway Walls and Other Mediums”, filed Apr. 14, 2003, which is incorporated by reference herein in its entirety.
• Additionally, devices and methods for treating airway walls are described in U.S. patent application Ser. Nos. 09/095,323 titled METHOD AND APPARATUS FOR TREATING SMOOTH MUSCLES IN THE WALLS OF BODY CONDUITS filed Jun. 10, 1998; 10/414,253 titled MODIFICATION OF AIRWAYS BY APPLICATION OF ENERGY filed Apr. 14, 2003; 09/436,455 titled DEVICES FOR MODIFICATION OF AIRWAYS BY TRANSFER OF ENERGY filed Nov. 8, 1999; 09/999,851 titled METHOD FOR TREATING AN ASTHMA ATTACK filed Oct. 25, 2001; 10/810,276 titled METHOD OF TREATING AIRWAYS IN THE LUNG filed Mar. 26, 2004; 10/640,967 titled METHODS OF TREATING ASTHMA filed Aug. 13, 2003; 10/809,991 titled METHODS OF TREATING REVERSIBLE OBSTRUCTIVE PULMONARY DISEASE filed Mar. 26, 2004; and 10/954,895 titled INACTIVATION OF SMOOTH MUSCLE TISSUE filed Sep. 30, 2004; and U.S. Pat. Nos. 6,411,852 titled CONTROL SYSTEM AND PROCESS FOR APPLICATION OF ENERGY TO AIRWAY WALLS AND OTHER MEDIUMS; and 6,634,363 titled DEVICES FOR MODIFICATION OF AIRWAYS BY TRANSFER OF ENERGY. Each of which of the above are incorporated by reference herein in their entirety
• In one embodiment, theRF generator12 generates RF energy at a frequency of about 400 kHz to about 500 kHz in with a wattage output sufficient to maintain a target tissue temperature of about 60 degrees C. to about 80 degrees C., specifically, about 60 degrees C. to about 70 degrees C. The duration of the activation state for an embodiment of a single treatment cycle may be about 5 seconds to about 15 seconds, specifically, about 8 seconds to about 12 seconds. Alternatively, the duration of the activation state of the RF generator may also be set to not more than the duration required to deliver about 150 Joules of energy to the target tissue, specifically, not more than the duration required to deliver about 125 Joules of RF energy to target tissue.
• The initiation of the activation state of theRF generator12 may be carried out by a variety of devices and methods, however, the embodiment ofFIG. 1 includes a user operated activation switch in the form thefootswitch26. Aconductive cable70 is coupled to and disposed between the footswitch26 and aproximal coupler72 which is configured to be electrically coupled to therespective interface coupler30 disposed on theuser interface surface16. Theinterface coupler30 for theproximal coupler72 of thefootswitch26 is disposed adjacent agraphical representation74 of thefootswitch26 on theuser interface surface16. Thefootswitch26 may be used in some configurations to initiate an activation state of theRF energy generator12 if all components of thesystem10 are functioning and connected properly. This can be defined as the controller entering into the ready mode.
• Referring now toFIG. 4, a more detailed view of an embodiment of theuser interface surface16 is shown. Theuser interface surface16 may be a substantially rectangular and flat surface as shown inFIG. 4, but may also have any other suitable shape, size or configuration. Theuser interface surface16 may, in some embodiments, be any part of an energy delivery system, or component thereof, that a user may access or see in order to impart information or receive information therefrom. Thecontroller14 may have an alternating current (AC) power on/off switch that may be located anywhere on thecontroller14, or alternatively, on theuser interface surface16. However, for the embodiment shown inFIG. 4, theuser interface surface16 does not include an AC power on/off switch. Thecontroller14 oruser interface surface16 may include an audio tone generator (not shown) which may be used in conjunction with the various visual indicators of thesystem10 to alert a user to the status of the various components of thesystem10. In one embodiment, the audio tone generator includes a speaker (not shown) which may be mounted on any suitable surface of thecontroller12 or theuser interface surface16.
• Theuser interface surface16 has a visual indicator in the form of a multi-colored LED (light emitting diode) ready indicator light76 in the upper left hand corner of theuser interface surface16. The ready indicator light76 may be activated or lit with a first color, such as a green color, when theRF energy generator12 is ready for use in a standby state. TheLED indicator76, may be activated and lit with a second color, such as an amber color, when theRF energy generator12 is switched on into an activation state at which time a brief audio tone may also sound upon the transition of theRF generator12 from the standby or ready state to the activation state with RE energy being delivered to theenergy emission element46 of theenergy delivery catheter18. Additionally, aseparate LED indicator92 may be activated and lit with a second color, such as a blue color, during RF energy delivery. Typically, a user activates theRF energy generator12 for a treatment cycle by depressing and releasing thefootswitch26. The color of the ready indicator light76 may be switched back to the first color if, during an activation cycle, thefootswitch26 of thesystem10 is depressed and released again so as to produce a footswitch shutoff response from theprocessor22 which switches theRE energy generator12 from the activation state to the standby state. The second color or amber color may also be displayed by the ready indicator light76 when thesystem10 is engaged in a power on self-test (POST) mode during which time the audio tone generator may be delivering a constant single pitch tone. In addition, the second amber color may also be displayed by the ready indicator when a fault with theenergy delivery catheter18, such as abroken electrode46 orbroken thermocouple52, is detected by thecontroller14. The activation of the second color indicating a fault with theenergy delivery catheter18 may also be accompanied by an audible first error tone from the audio tone generator. The ready indicator light76 may flash the first color, green, when thesystem10 is conducting a cycling of the AC power to thecontroller14 in order to reset thesystem10 during which time the audible first error tone may also be produced. In essence, theready indicator light76 emits a first color when thesystem10 is ready to use and a second color or amber color if thesystem10 has detected a fault in thesystem10 and is not ready to use.
• Below the LEDready indicator76 is thegraphical representation74 of thefootswitch26 which is printed on theuser interface surface16. Thegraphical representation74 of thefootswitch26 is directly above and adjacent to theinterface coupler30 which is configured to accept theproximal coupler72 of thefootswitch26 assembly. Thegraphical representation74 of thefootswitch26 adjacent theinterface coupler30 for thefootswitch26 provides an intuitive and user friendly prompt for the user to locate the plug in point for thefootswitch26 while setting up thesystem10.
• To the right of thegraphical representation74 of thefootswitch26 is thegraphical representation68 of theelectrode return assembly62 which includes theconductive pad24,conductive cable66 andproximal coupler64 and which is printed on theuser interface surface16. Thegraphical representation78 of theproximal coupler64 of theelectrode return assembly62 is disposed directly above and adjacent to theinterface coupler28 for theproximal coupler64 of theelectrode return assembly62. A visual indicator in the form of an amber coloredLED light80 is disposed within thegraphical representation82 of theconductive pad24 of theelectrode return assembly62 and on theuser interface surface16. Thevisual indicator80 may be configured to be lighted in a steady state when thesystem10 is proceeding through the POST which may also be accompanied by a single pitch audible tone from the audio tone generator. Thevisual indicator80 may also be activated and lighted when thecontroller14 measures an impedance in the patient circuit that is above a predetermined value after 3 or more attempts to activate the RF energy generator to the activation state. A second error tone may accompany the activation of the visual indicator in this circumstance. For some embodiments, the predetermined impedance value for the patient circuit may be above about 1000 Ohms, specifically, above about 900 Ohms. Such a high impedance measurement in the patient circuit indicates an open circuit and requires that the user check the patient circuit and try thesystem10 another time. The patient circuit includes theelectrode46 andconductive cable38 of theenergy delivery catheter18, the patient (not shown) with theconductive pad24 andelectrode46 in electrical communication with the patient's body, and theelectrode return assembly62, Thevisual indicator80 may also be activated or lighted in a flashing mode when a fault requiring the user to cycle AC power has been initiated by theprocessor22, during which time a first audible error tone may also be generated by the audio tone generator.
• To the right of thegraphical representation68 of theelectrode return62, thegraphical representation60 of theenergy delivery catheter18 is printed on theuser interface surface16 including thehandle36, theelongate shaft34 and thedistal electrode basket44. Theinterface coupler20 configured to accept theproximal coupler40 of theenergy delivery catheter18 is disposed adjacent and directly below agraphical representation84 of thehandle36 of theenergy delivery catheter18. A first visual indicator in the form of anamber LED light86 is disposed within thegraphical representation88 of thedistal electrode basket44 on theuser interface surface16. A secondvisual indicator90, having a second color different from the first visual indicator, in the form of ared LED light90 is disposed within thegraphical representation84 of thehandle36.
• The firstvisual indicator86 may be activated and lighted for some embodiments of thesystem10 when thecontroller14 measures an impedance in the patient circuit that is above a predetermined value. For some embodiments, the predetermined impedance value for the patient circuit may be above about 1000 Ohms, specifically, above about 900 Ohms. A first audible error tone may also be generated during such an activation. The firstvisual indicator86 may also be lighted or activated when the measured impedance of the patient circuit is above such a predetermined value during at least 3 or more attempts to activate theRE energy generator12 to the activation state. In this circumstance, a second audible error tone may also be generated in conjunction with the activation of the firstvisual indicator86. The firstvisual indicator86 may also be lighted in a steady state when theprocessor22 of thesystem10 is proceeding through the POST which may also be accompanied by a single pitch audible tone from the audio tone generator. Thevisual indicator86 may also be activated or lighted in a flashing mode when a fault requiring the user to cycle AC power has been initiated by theprocessor22, during which time a first audible error tone may also be generated by the audio tone generator.
• The secondvisual indicator90 may be activated or lighted in a flashing or intermittent mode when a fault with theenergy delivery catheter18, such as abroken electrode46 orbroken thermocouple52, is detected by thecontroller14. The activation of the secondvisual indicator90 suggesting a fault with theenergy delivery catheter18 may also be accompanied by an audible first error tone from the audio tone generator. The secondvisual indicator90 may also be lighted in a steady state when theprocessor22 of thesystem10 is proceeding through the POST which may also be accompanied by a single pitch audible tone from the audio tone generator. The secondvisual indicator90 may also be activated or lighted in a flashing mode when a fault requiring the user to cycle AC power has been initiated by theprocessor22, during which time a first audible error tone may also be generated by the audio tone generator.
• Anothervisual indicator92 in the form of a graphical representation of a radiating electrode is disposed on theuser interface surface16. ThisRF energy indicator92, which may be a third color or blue LED, is activated or lighted in a flashing mode during the time when theRF energy generator12 is switched to the activation state and delivering RE energy to theenergy delivery catheter18. TheRE energy indicator92 may also be lighted in a steady state when theprocessor22 of thesystem10 is proceeding through the POST which may also be accompanied by a single pitch audible tone from the audio tone generator. TheRE energy indicator92 may also be activated or lighted in a flashing mode when a fault requiring the user to cycle AC power has been initiated by theprocessor22, during which time a first audible error tone may also be generated by the audio tone generator.
• Adigital display94 is disposed on theuser interface surface16 below theRE energy indicator92 and is configured to display numerical information. Thedigital display94 may be controlled or otherwise reset by aswitch96 disposed directly below thedigital display94 on theuser interface surface16. In a normal mode, thedigital display94 will display the number of successful treatment cycles delivered by thesystem10 performed by a user of thesystem10. If theswitch96 is depressed for less than about 2 seconds to about 4 seconds, the number of unsuccessful or incomplete treatment cycles is displayed for a brief period, such as about 5 seconds. After this brief period, thedigital display94 reverts back to a display of the number of completed treatment cycles. When theswitch96 is depressed and held for more than a brief period of about 2 seconds to about 4 seconds, thedigital display94 shows a “0” for a short period, such as about 1 second. If theswitch96 is held depressed during this short 1 second period, the count of the complete and incomplete treatment cycles is reset to 0. If theswitch96 is released during this short 1 second period, thedigital display94 reverts back to a display of the completed or successful treatment cycles without resetting the treatment cycle counter.
• Referring toFIG. 5, a variety of system process embodiments are shown in flow diagram form. In use, thesystem10 for delivery of therapeutic energy is first supplied with power, such as AC power, which may be carried out by a switch (not shown) on thecontroller14 oruser interface surface16, as discussed above. Once AC power is supplied to thecontroller14, theprocessor22 initiates the POST cycle, indicated bybox100, which tests the integrity of theprocessor22, thecontroller14 and thesystem10 generally. If the POST fails, the user initiates a cycling of the AC power in order to reboot thecontroller14, and specifically, theprocessor22 of thecontroller14. In addition, once AC power has been supplied to thecontroller14, theprocessor22 continually runs a first background algorithm, indicated by the decision point “irrecoverable error”102. The irrecoverable error test checks for hardware and processor errors such as CPU configuration, COP timeout, ROM CRC error, RAM, illegal CPU instruction, software, non-volatile memory, RF current measurement errors. If such an error is detected, the user should initiate a cycling of the AC power, as indicated bybox111, in order to reboot thecontroller14, and specifically, theprocessor22 of thecontroller14. During the cycling of the AC power, the user will be informed of the cycling status by a flashing of all visual indicators on theuser interface surface16 as well as a flashing of thedigital display94 and the concurrent generation of an audible error tone.
• If the POST is successful, theprocessor22 will initiate a test algorithm that determines whether all connections of system components, such as theenergy delivery catheter18,return electrode62 andfootswitch26 are all properly coupled to therespective interface couplers20,28 and30 of theuser interface surface16, as indicated bydecision point104. If an error is detected during this routine, the ready indicator light76 will remain in the second or amber color state, indicating that theRF energy generator12 is not ready or in the standby state. Once the system components such as theenergy delivery catheter18,electrode return62 andfootswitch26 are properly coupled to theuser interface16, theprocessor22 will initiate an algorithm that determines whether the temperature detection element, orthermocouple52, of theenergy delivery catheter18 is properly functioning as indicated bybox106
• During this test, theprocessor22 measures the temperature indicated by thethermocouple52 and compares the result to a predetermined temperature range, that encompasses room temperature for some embodiments. For example, the predetermined temperature range for some embodiments may be about 15 degrees C. to about 35 degrees C, specifically, about 20 degrees C. to about 30 degrees C. If the measured temperature indicated by thethermocouple52 does not fall within the predetermined temperature range, theprocessor22 indicates abroken thermocouple52 by initiating an error message to the user which includes switching the ready indicator light76 to the second or amber color in addition to initiating a flashing mode activation of the red LED secondvisual indicator90 in thehandle84 of thegraphical representation60 of theenergy delivery catheter18. An audible error tone may also accompany the error message generated by thevisual indicators76 and90. These error messages inform the user that it may be necessary to replace theenergy delivery catheter18 with a new one.
• Once the thermocouple test has been successfully performed, theprocessor22 will switch the ready indicator light76 to the first color or green color indicating that thesystem10 is now ready to perform a treatment cycle in a patient, as indicated bybox108. At this point, the user may then position thedistal electrode basket44 of theenergy delivery catheter18 such that at least one emission element orelectrode46 is disposed adjacent target tissue of the patient, such as smooth muscle of the patient's bronchial airways. Once theelectrode46 is properly positioned, the user depresses thefootswitch26 to initiate a treatment cycle, as indicated by user action/input box110. Upon depression of thefootswitch26, theprocessor22 immediately measures the impedance of the patient circuit, and if the impedance is below a predetermined maximum or within a predetermined impedance range, theprocessor22 switches theRF energy generator12 from the ready or standby state to the activation state wherein RF energy is being delivered to the target tissue of the patient for the initiation of a treatment cycle.
• For some embodiments of a normal treatment cycle, as indicated byresult box112, theprocessor22 and algorithms run by theprocessor22 are configured to maintain theRF energy generator12 in the activation state for a dwell time of about 5 seconds to about 15 seconds, specifically, about 8 seconds to about 12 seconds. The duration of the treatment cycle may also be constrained by the total energy delivered to the target tissue during the cycle. For example, theprocessor22 may execute an algorithm which terminates the treatment cycle when the total energy delivered to the target tissue is up to about 150 Joules, specifically, up to about 125 Joules. During the treatment cycle, theprocessor22 controls the output of theRF energy generator12 in order to maintain a substantially constant temperature of the target tissue. The temperature of the target tissue during a treatment cycle embodiment may be maintained at a temperature of about 60 degrees C. to about 80 degrees C., specifically, from about 60 degrees C. to about 70 degrees C. As discussed above, theprocessor22 is able to maintain the substantially constant temperature of the target tissue by monitoring the temperature of the target tissue via the temperature measuring element orthermocouple52 and processing the temperature information in a feedback loop with lowers theRF energy generator12 output if the measured temperature is higher than desired and increasing the RF energy generator output if the measured temperature is lower than desired.
• During the treatment cycle, theprocessor22 will switch the blue RF energyvisual indicator92 to an activated solid or flashing mode and will activate the audio signal generator to generate a dual pitch audible tone from the audible tone generator that repeats a high pitch then low pitch audible tone during the treatment cycle, followed by a long single pitch tone at the end of a successful cycle. If an error occurs in the middle of a treatment cycle, an audible error tone will be generated and the visual indicator or indicators indicative of the error will be activated as discussed above. As discussed above, a treatment cycle may also be interrupted by the user's depression of thefootswitch26 during the treatment cycle to initiate a footswitch shutoff, as indicated byuser action box114. This may be done if the user feels that thesystem10 is operating improperly for any reason, the user feels that the location of theelectrode46 is wrong, or for any other reason. A footswitch shutoff action by the user returns thesystem10 to the RF generator ready state, indicated bybox108, but does not log a completed or successful treatment cycle on thedigital display94. If the treatment cycle is successfully completed, thedigital display94 will display a count of “1”, indicating one successfully completed treatment cycle.
• If an error occurs during the treatment cycle, as indicated byresult box116, or the footswitch shutoff option is used, a “0” will remain displayed. However, if thedisplay control switch96 is depressed for more than about 2 seconds to about 4 seconds, thedigital display94 will show a “1”, indicating one incomplete or unsuccessful treatment cycle. The user may continue to deploy theenergy delivery catheter18 to new locations within the patient's anatomy and activate theRF energy generator12 to the activation state for any desired number of treatment cycles. If an error occurs during a treatment cycle, as indicated byresult box116, theuser interface16 will then display via the appropriate visual indicators and audible tone indicators, the type of error that has occurred and will recommend a course of action for the user. After correction has been attempted by the user, thefootswitch26 may again be depressed, as indicated by user action/input box118, in order to initiate another treatment cycle.
• If the impedance of the patient circuit is greater than a predetermined maximum or not within a predetermined impedance range upon depression of thefootswitch26, as indicated byresult box120, one of two error messages including visual indicators and audible tones may be generated by thesystem10. Specifically, if a high impedance is measured upon a first depression of thefootswitch26 or a second depression of thefootswitch26, as indicated bybox122, the error message “improve deployment and continue” will be generated, as discussed above, whereby the ambervisual indicator86 of the distal basket graphic88 on theuser interface16 will be activated and lighted and a first error tone will be generated by the audible tone generator. In addition, an incomplete treatment cycle will be logged by thedigital display94. Once attempted correction has been made, thefootswitch26 may again be depressed as indicated by user action/input box124, in which case the treatment cycle is reinitiated.
• If on the third or subsequent depression of thefootswitch26 the same error is detected by thesystem10, the “check patient circuit” error message will be generated, as discussed above, whereby the ambervisual indicator80 of the return electrode graphic82 and the ambervisual indicator86 of the electrode basket graphic88 on theuser interface surface16 will be activated and lighted. Such an error message may also be accompanied by a second audible error tone generated by the audible tone generator. In addition, an incomplete treatment cycle will be logged by thedigital display94. After attempted correction of the error, thefootswitch26 may again be depressed, as indicated by user action/input box126, in order to initiate another treatment cycle.
• With regard to the above detailed description, like reference numerals used therein refer to like elements that may have the same or similar dimensions, materials and configurations. While particular forms of embodiments have been illustrated and described, it will be apparent that various modifications can be made without departing from the spirit and scope of the embodiments of the invention. Accordingly, it is not intended that the invention be limited by the forgoing detailed description.

Claims (2)

1. A system for delivering activation energy to a therapeutic energy delivery device having a temperature detecting element and an energy emission element, the system comprising:

an energy generator configured to be coupled to the energy emission element and having an activation state and a standby state, wherein activation energy is delivered to the energy emission device in the activation state and not in the standby state;

a controller having a processor and a user interface surface with at least one visual indicator, the processor being configured to activate a visual indicator when a temperature measured by the temperature detecting element is not within a pre-determined range.

2-70. (canceled)

Images